The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index; none of the 5 sources its claims cite is checked for support yet.
Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
Open accessAbstract
BACKGROUND: Global deaths from cardiovascular disease are increasing as a result of population growth, the aging of populations, and epidemiologic changes in disease. Disentangling the effects of these three drivers on trends in mortality is important for planning the future of the health care system and benchmarking progress toward the reduction of cardiovascular disease. METHODS: We used mortality data from the Global Burden of Disease Study 2013, which includes data on 188 countries grouped into 21 world regions. We developed three counterfactual scenarios to represent the principal drivers of change in cardiovascular deaths (population growth alone, population growth and aging, and epidemiologic changes in disease) from 1990 to 2013. Secular trends and correlations with changes in national income were examined. RESULTS: Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth. The relative contributions of these drivers varied by region; only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline. Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere. CONCLUSIONS: The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions. Only Central and Western Europe had gains in cardiovascular health that were sufficient to offset these demographic forces. (Funded by the Bill and Melinda Gates Foundation and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 5 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For the most common cause of cardiovascular death, ischemic heart disease, the number of deaths increased by an estimated 41.7% from 1990 to 2013.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Even larger declines (more than 55%) were seen as a result of epidemiologic changes in the risk of hemorrhagic stroke.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“According to our estimates, epidemiologic change led to an increase in cardiovascular deaths in only one region of the world (western sub-Saharan Africa).”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The combination of increases in the number of deaths due to population growth and population aging and declines in age-specific death rates represented the most common epidemiologic profile among the specific cardiovascular causes of death (Table 1).”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas population growth contributed to an estimated 23.6% increase.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Rheumatic heart disease was the only cardiovascular condition for which there were fewer total deaths globally in 2013 than in 1990.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ischemic heart disease was the largest contributor to the increase in the number of cardiovascular deaths (2.4 million of the overall increase of 5.0 million cardiovascular deaths)”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Central Europe and Western Europe, which had declines of an estimated 5.2% and 12.8%, respectively.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“East Asia reported more than 1.2 million additional deaths in 2013, representing a 47.2% increase from 1990.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline.”
- Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
“The only regions with a significant decrease in cardiovascular deaths were Central Europe and Western Europe, which had declines of an estimated 5.2% and 12.8%, respectively.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > Abstract > RESULTS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
- It may state two separate claims as one. 10
- The quote only partly states this claim. 1
- Probably not a substantial claim. 8
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere.”
- Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
“the two variables had a significant correlation only within the category of upper-middle income.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > Abstract > RESULTS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Southern Latin America, Australasia, and high-income North America had no detectable change in the number of deaths from 1990 to 2013 (as indicated by an uncertainty interval crossing 0) because population aging and growth balanced out declines in age-specific death rates.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Atrial fibrillation or flutter and peripheral vascular disease are notable exceptions to the demographic and epidemiologic pattern for cardiovascular disease. Deaths from each of these conditions increased dramatically between 1990 and 2013, driven not only by population growth and aging but also by increases in age- and sex-specific death rates.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In absolute terms, South Asia had the largest estimated increase in deaths from cardiovascular disease, reporting more than 1.7 million more deaths in 2013 than in 1990. This change represents an increase of 97.4% (95% uncertainty interval, 72 to 126.1).”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For example, there were 349,153 cardiovascular deaths in the high-income Asia–Pacific region in 1990. In 2013, there were 487,170 cardiovascular deaths, which is less than the 910,042 that would have been expected if 1990 death rates had remained constant, given the population size and the age structure in that region in 2013.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > METHODS > DETERMINATION OF DRIVERS OF CARDIOVASCULAR MORTALITY
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most countries had an increase in income per capita and a decline in the number of cardiovascular deaths due to epidemiologic change.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“despite a 39% decrease in age-specific death rates”
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
“despite a decrease in deaths attributable to epidemiologic changes of 39.3% (95% uncertainty interval, 33.6 to 44.1)”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > Abstract > RESULTS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This pattern was also present in trends for ischemic heart disease, ischemic stroke, hemorrhagic and other nonischemic causes of stroke, hypertensive heart disease, cardiomyopathy, myocarditis, aortic aneurysm, and endocarditis.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“These changes are probably due to the combined effect of birth cohorts’ decreased exposure to tobacco smoking, improvements in diet, and improved treatment of cardiovascular disease and cardio-metabolic risk factors targeting the prevention of cardiovascular disease, and improved treatment of cardiovascular disease.10”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
What the sources say
- Not checked yetcites [10] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, South Asia had a dramatic rise in cardiovascular deaths due to population growth and aging without a significant decline in cardiovascular deaths due to epidemiologic change.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the rigorous out-of-sample predictive validity testing used in GBD 2013 is cause for some confidence.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“As they have noted, the classic model of “epidemiologic transition” does not fully reflect the heterogeneity of the burden of cardiovascular disease across countries.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A deterministic health policy model indicated that 40 to 55% of the decline in coronary heart disease in high-income countries can be attributed to the effects of medical and surgical treatments.12”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
What the sources say
- Not checked yetcites [12] source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, we recognize that patterns of disease burden vary not just between but also within countries. Any summary provided at the level of a region or country may mask significant disparities within that area.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“However, calculations made with the traditional Shapley method and other methods used in econometrics may produce different results.6”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
What the sources say
- Not checked yetcites [6] source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“First, cause-specific mortality data are lacking or of limited quality in some countries.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, the number of deaths resulting from rheumatic heart disease may not be completely captured by vital records in regions in which the condition is endemic.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the remarkable increase in the age-specific rate of death from atrial fibrillation probably reflects increases in the screening, recognition, and attribution of death to atrial fibrillation in addition to changes in disease epidemiology.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ageing of the population also contributes to increasing the absolute number of CVD events. 17”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [17]
In the citing paper
“Ageing of the population also contributes to increasing the absolute number of CVD events.17”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [17]
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Universal Definition of Myocardial Infarction: Clinical Insights
Paiva, L., Providencia, R. A., Barra, S., Dinis, P., Faustino, C., & Gonçalves, L. M. M. (2015) · Cardiology · doi:10.1159/000371739 · Cited by 2,513
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576
Self-citationEmerging Epidemic of Cardiovascular Disease in Developing Countries
Reddy, K. S., & Yusuf, S. (1998) · Circulation · doi:10.1161/01.cir.97.6.596 · Cited by 1,206
Decomposition procedures for distributional analysis: a unified framework based on the Shapley value
Shorrocks, A. F. (2013) · The Journal of Economic Inequality · doi:10.1007/s10888-011-9214-z · Cited by 1,190
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. (2001) · Circulation · doi:10.1161/hc4701.099488 · Cited by 1,141
Ezzati, M., Hoorn, S. V., Lawes, C. M. M., Leach, R. J., James, W. P. T., López, A. D., Rodgers, A., & Murray, C. J. L. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020133 · Cited by 627
Self-citationModeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- GBD 2013 Mortality and Causes of Death Collaborators, 2014, Lancet, 385, 117
Cited by
Sorted by citations
Items 501–600 of 1,000
Zhao, M., Zheng, Z., Li, C., Wan, J., & Wang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053175 · Cited by 14
A Panoramic View of Ferroptosis in Cardiovascular Disease
Cheng, X., Yu, C., Yang, X., Wang, F., & Min, J. (2023) · Kidney Diseases · doi:10.1159/000530046 · Cited by 14
Yazji, K., Abdul, F. B., Elangovan, S., Ossei‐Gerning, N., Choudhury, A., Cockburn, J., Anderson, R., Mamas, M. A., & Kinnaird, T. D. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.031 · Cited by 14
Wallström, S., Balcan, B., Thunström, E. Ö., Wolf, A., & Peker, Y. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7926 · Cited by 15
Baptista, E. A., Kakinuma, K., & Queiroz, B. L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17041311 · Cited by 14
Pilania, M., Singh, T., Jat, G. S., & Kumar, R. (2018) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_255_17 · Cited by 14
Insufficient physical activity level among Sahrawi adults living in a protracted refugee setting
Andersen, E., Kjellså, I., Hjellset, V. T., & Henjum, S. (2021) · BMC Public Health · doi:10.1186/s12889-021-10217-w · Cited by 16
Najafipour, H., Afshari, M., & Rostamzadeh, F. (2018) · Europe PMC (PubMed Central) · Cited by 14
Zhang, X., Lv, W., Qiu, B., Zhang, L., Qin, J., Tang, F., Wang, H., Li, H., & Hao, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-25305-y · Cited by 14
Modifiable Risk Factors and Overall Cardiovascular Mortality: Moderation of Urbanization
Sajid, M. R., Muhammad, N., Zakaria, R., & Bukhari, S. A. C. (2020) · Journal of Public Health Research · doi:10.4081/jphr.2020.1893 · Cited by 13
Santiago‐Vacas, E., Anguita, M., Casado, J., García‐Prieto, C. F., González‐Costello, J., Matalí, A., Franco, Á. G., Trueba-Sáiz, Á., & Manzano, L. (2023) · Revista Clínica Española · doi:10.1016/j.rce.2023.04.004 · Cited by 13
Chen, X., Ding, J., Shi, Z., Bai, K., Shi, S., & Tian, Q. (2024) · BMC Public Health · doi:10.1186/s12889-024-18823-0 · Cited by 13
Huang, X., Song, J., Zhang, X., Wang, M., Ding, Y., Ji, X., Zhou, D., & Meng, R. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70258 · Cited by 13
Aminde, L. N., Dzudié, A., & Kengne, A. P. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010097 · Cited by 13
Perspectives from NHLBI Global Health Think Tank Meeting for Late Stage (T4) Translation Research
Engelgau, M. M., Peprah, E. K., Sampson, U. K. A., Mishoe, H. O., Benjamin, I. J., Douglas, P. S., Hochman, J. S., Ridker, P. M., Brandes, N., Checkley, W., et al. (2016) · Global Heart · doi:10.1016/j.gheart.2016.03.640 · Cited by 13
Self-citationMetallome evolution in ageingC. elegansand a copper stable isotope perspective
Sauzéat, L., Laurençon, A., & Balter, V. (2018) · Metallomics · doi:10.1039/c7mt00318h · Cited by 13
¿Se está desacelerando el ritmo de disminución de la mortalidad cardiovascular en España?
Cayuela, L., Gómez-Enjuto, S., Martínez, B. O., Rodríguez‐Domínguez, S., & Cayuela, A. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.07.017 · Cited by 14
Kornej, J., Huang, Q., Preis, S. R., Lubitz, S. A., Ko, D., Murabito, J. M., Benjamin, E. J., & Trinquart, L. (2021) · BMC Medicine · doi:10.1186/s12916-021-02037-x · Cited by 13
Achila, O. O., Araya, M., Berhe, A. B., Haile, N. H., Tsige, L. K., Shifare, B. Y., Bitew, T. A., Berhe, I. E., Mengistu, S. T., & Garoy, E. Y. (2021) · Journal of Lipids · doi:10.1155/2021/6155304 · Cited by 13
Ding, J., Chen, X., Shi, Z., Bai, K., & Shi, S. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s397243 · Cited by 13
Schmidt-Rimpler, J., Backhaus, S. J., Hartmann, F., Schaten, P., Lange, T., Evertz, R., Schulz, A., Kowallick, J. T., Lapinskas, T., Hasenfuss, G. P., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131563 · Cited by 13
López-Messa, J. B., de Llano, J. M. A., López-Fernández, L., García-Cruces, J., García-Crespo, J., & Prieto-González, M. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.04.033 · Cited by 13
Noninvasive monitoring of blood flow using a single magnetic microsphere
Liebl, M., Gleich, B., Eberbeck, D., Radon, P., Rahmer, J., Trahms, L., & Wiekhorst, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-41416-6 · Cited by 13
Cardiovascular medicine and research in sub-Saharan Africa: challenges and opportunities
Zuhlke, L. J., Sliwa, K. S., Naidoo, P., Ntsinjana, H. N., Ntsekhe, M., Hellig, F., Smit, F. E., Jankelow, D., Subahi, S., Dyer, R., et al. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0269-z · Cited by 13
Yang, S., Zheng, X., Qian, M., Wang, H., Wang, F., Wei, Y., Midgley, A. C., He, J., Tian, H., & Zhao, Q. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.770121 · Cited by 13
Khan, M. A., Laakso, H., Laidinen, S., Kettunen, S., Heikura, T., Ylä‐Herttuala, S., & Liimatainen, T. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3871 · Cited by 13
The Association Between Symptoms of Anxiety, Depression, and Cardiovascular Risk Factors
Rioli, G., Tassi, S., Mattei, G., Ferrari, S., Galeazzi, G. M., Mancini, S., Alboni, S., & Roncucci, L. (2019) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000969 · Cited by 14
Molecular Scavengers, Oxidative Stress and Cardiovascular Disease
Minno, A. D., Stornaiuolo, M., & Novellino, E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111895 · Cited by 13
RISHAD, S., MCENTEGART, M., FORD, T. J., MARIO, C. D., FAJADET, J., LINDSAY, M., WATKINS, S., ETEIBA, H., BROGAN, R., Richard, G. O. O. D., et al. (2021) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.21.05681-7 · Cited by 12
Tsilimigras, D. I., Thanopoulou, K., Salagianni, M. L., Siasos, G., Oikonomou, E. K., Perrea, D. N., Nirakis, N., Filis, K., Tsioufis, K. P., Tousoulis, D. M., et al. (2023) · In Vivo · doi:10.21873/invivo.13173 · Cited by 12
Okube, O. T., Kimani, S. T., & Mirie, W. (2023) · SAGE Open Nursing · doi:10.1177/23779608231201044 · Cited by 13
Abdullah, S., & Kristoffersson, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1285066 · Cited by 12
Could the periodontal therapy improve the cardiologic patient health? A narrative review
Bertoldi, C., Salvatori, R., Pinti, M., & Mattioli, A. V. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102699 · Cited by 14
Focusing on microvascular function in heart failure with preserved ejection fraction
Velollari, O., Rommel, K., Kresoja, K., Lurz, P. C., & Gori, T. (2025) · Heart Failure Reviews · doi:10.1007/s10741-024-10479-7 · Cited by 12
Martínez‐García, I., Cavero‐Redondo, I., Pascual‐Morena, C., Otero-Luis, I., Fenoll-Morante, M., Lever‐Megina, C. G., Rodríguez‐Gutiérrez, E., & Saz‐Lara, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020474 · Cited by 12
Sasko, B. M., Kelesidis, T., Sawa Kostin, D., Scharow, L., Mueller, R., Jänsch, M., Wintrich, J., Christ, M., Ritter, O., Ukena, C., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02583-3 · Cited by 12
Panova‐Noeva, M., Eggebrecht, L., Prochaska, J. H., & Wild, P. S. (2019) · Hämostaseologie · doi:10.1055/s-0038-1677520 · Cited by 12
Determinants of Mortality from Cardiovascular Disease in the Slums of Nairobi, Kenya
Wekesah, F. M., Klipstein‐Grobusch, K., Grobbee, D. E., Kadengye, D. T., Asiki, G., & Kyobutungi, C. K. (2020) · Global Heart · doi:10.5334/gh.787 · Cited by 13
Dillinger, J., Ducrocq, G., Elbez, Y., Cohen, M. C., Bode, C., Pollack, C. V., Petrauskienė, B., Henry, P., Dorobanţu, M., French, W. J., et al. (2021) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.009759 · Cited by 12
Lim, S., Choo, E. H., Choi, I. J., Lee, K. Y., Lee, S. N., Hwang, B., Kim, C. J., Park, M., Lee, J. M., Park, C. S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163642 · Cited by 12
Scholten, M., Midlöv, P., & Halling, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-051997 · Cited by 12
Xu, Q., Wang, X., Bai, Y., Zheng, Y., Duan, J., Du, J., & Wu, X. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2154382 · Cited by 12
Novel risk factors for acute coronary syndromes and emerging therapies
Tong, D. C., Wilson, A., & Layland, J. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.148 · Cited by 12
Body fat distribution: the answer to the apparent paradox of obesity in cardiology?
Borodkinа, D. A., Gruzdeva, O. V., Kvitkova, L. V., & Барбараш, О. Л. (2017) · Obesity and metabolism · doi:10.14341/omet201723-8 · Cited by 12
Inheritance of high and low HDL: mechanisms and management
Sourlas, A., & Kosmas, C. E. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000610 · Cited by 13
Using a 3D printer in cardiac valve surgery: a systematic review
Boll, L. F. C., Rodrigues, G. O., Rodrigues, C. G., Bertollo, F. L., Irigoyen, M. C., & Goldmeier, S. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.6.818 · Cited by 12
Association between birth weight and childhood cardiovascular disease risk factors in West Virginia
Umer, A., Hamilton, C., Cottrell, L., Giacobbi, P. R., Innes, K. E., Kelley, G. A., Neal, W. A., John, C. C., & Lilly, C. L. (2019) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s204017441900045x · Cited by 12
Kaestner, T. L. D. L., Santos, J. A. D., Pazin, D. C., Baena, C. P., Olandoski, M., Abreu, G. D. A., Kuschnir, M. C. C., Bloch, K. V., & Faria‐Neto, J. R. (2020) · Global Heart · doi:10.5334/gh.769 · Cited by 12
Bai, Y., Huang, R., Wan, L., & Zhao, R. (2020) · Journal of International Medical Research · doi:10.1177/0300060520934657 · Cited by 12
dos Santos, R. Z., Ghisi, G. L. D. M., Bonin, C. D. B., Chaves, G., Haase, C. M., Britto, R. R., & Benetti, M. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180244 · Cited by 12
Fiolet, A. T. L., Keusters, W. R., Blokzijl, J., Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., Tijssen, J. G. P., Römer, T. J., Westendorp, I. C. D., Cornel, J. H., et al. (2024) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae021 · Cited by 11
Qing-xia, Y., & Yu, S. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436182.56 · Cited by 11
Hasani, W. S. R., Musa, K. I., Cheng, K. Y., & Dass, S. C. (2024) · BMC Public Health · doi:10.1186/s12889-024-19103-7 · Cited by 11
Liu, J., & Kim, J.-H. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105663 · Cited by 12
Qin, R., Xu, W., Xu, J., Qin, Q., Liang, X., Lai, X., Shao, L., Xie, M., Xiong, X., Tang, Q., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13074-4 · Cited by 11
Gao, Y., Li, Y., Jiang, N., Gao, R. H., Zhang, Y., Feng, Z., Zhang, C., Wang, L., Wang, W., Kong, D., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.06.034 · Cited by 12
Hirai, K., Imamura, S., Hirai, A., Ookawara, S., & Morishita, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072256 · Cited by 11
Sarı, A., Davutoğlu, V., Bozkurt, E., Tarakçıoğlu, M., & Ercıyas, K. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104961 · Cited by 11
Shear stress-induced MMP1 and PDE2A expressions in coronary atherosclerosis
Ma, Y. S., Xie, Y., Ma, D., Zhang, J. J., & Liu, H. J. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_048 · Cited by 11
Vascular Graft Infections: An Overview of Novel Treatments Using Nanoparticles and Nanofibers
He, E., Serpelloni, S., Alvear, P., Rahimi, M., & Taraballi, F. (2022) · Fibers · doi:10.3390/fib10020012 · Cited by 11
Bell, S. P., & Rich, M. W. (2021) · Springer eBooks · doi:10.1007/978-3-030-76271-1_19 · Cited by 11
NAD + Levels Are Augmented in Aortic Tissue of ApoE −/− Mice by Dietary Omega-3 Fatty Acids
Chi, D. H., Kahyo, T., Islam, A., Hasan, M. M., Waliullah, A. S. M., Mamun, M. A., Nakajima, M., Ikoma, T., Akita, K., Maekawa, Y., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.317166 · Cited by 11
Targeting the Metabolic-Inflammatory Circuit in Heart Failure With Preserved Ejection Fraction
Yap, E. P., Ja, K. P. M. M., & Ramachandra, C. J. A. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00546-1 · Cited by 11
Genetic analysis of DNA methylation in dyslipidemia: a case-control study
Ma, Y.-T., Li, Y., Li, Y., Wei, X., Adi, D., Wang, Y.-T., Min, H., Liu, F., Chen, B.-D., Li, X.-M., et al. (2022) · PeerJ · doi:10.7717/peerj.14590 · Cited by 11
Elkammash, A., Tam, S. S. C., Yogarajah, G., & You, J. (2023) · Cureus · doi:10.7759/cureus.35030 · Cited by 12
Lerman, T. T., Greenberg, N., Fishman, B., Goldman, A., Talmor‐Barkan, Y., Bauer, M., Goldberg, I., Goldberg, E., Kornowski, R., Krause, I., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131613 · Cited by 11
Cardiovascular side effects of psychopharmacologic therapy
Potočnjak, I., Degoricija, V., Vukičević-Baudoin, D., Čulig, J., & Jakovljević, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.057 · Cited by 12
Montalvan-Sanchez, E. E., Urrutia, S., Rodriguez-Murillo, A. A., Duarte, G., Murillo, A. A., Rivera, R., Henriquez, A. A. P., Montalvan-Sanchez, D. M., Ordoñez, E., Norwood, D. A., et al. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100476 · Cited by 11
Developing long-term strategies to reduce excess salt consumption in Nigeria
Ojji, D. B., Nigeria Sodium Study Team, Huffman, M. D., Ojo, A. E., Alfa, V. O., Okoro, C. E., Shedul, G. L., Orji, I. A., Ojo, T. M.-F., Ale, B. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac025 · Cited by 11
Balbaa, A., ElGuindy, A. M., Pericak, D., Natarajan, M. K., & Schwalm, J. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.100978 · Cited by 11
Barriuso, I., Worner, F., & Vilahur, G. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110397 · Cited by 11
Chen, C.-T., Chen, C., Chen, T., Yen, D. H.-T., How, C., & Hou, P. C. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000343 · Cited by 11
Wang, W., Zhao, Y., Zhu, P., Jia, X., Wang, C., Zhang, Q., Li, H., Wang, J., & Hou, Y. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-022-07365-5 · Cited by 10
Sivanantham, P., Mathan Kumar, S., Essakky, S., Singh, M., Ghosh, S., Mehndiratta, A., & Kar, S. S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285542 · Cited by 10
Doku, A., Tetteh, J., Edzeame, J., Peters, R. J. G., Agyemang, C. O., Otchi, E. H., & Yawson, A. E. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1330708 · Cited by 10
Ultrasound-measured Quadriceps Muscle Thickness and Mortality in Older Patients With Heart Failure
Saito, H., Fujimoto, Y., Matsue, Y., Yoshioka, K., Maekawa, E., Kamiya, K., Toki, M., IWATA, K., Saito, K., Murata, A., et al. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.09.007 · Cited by 10
Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence
Zhou, Z., Li, T., Qin, H., Wang, X., He, S., Fan, Z., Ye, Q., & Du, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1493981 · Cited by 11
Epigenetic impact of endocrine-disrupting chemicals on atherosclerosis
Lin, T.-A., & Zhou, C. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253022 · Cited by 11
Perioperatives Risiko und Letalität nach großen chirurgischen Eingriffen
Boehm, O., Pfeiffer, M., Baumgarten, G., & Hoeft, A. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0110-y · Cited by 10
Kalp Yetersizliği Hastalarında Ölüm Kaygısının Belirlenmesi
Bayrak, B. (2019) · Journal of Cardiovascular Nursing · doi:10.5543/khd.2019.09226 · Cited by 10
Szolc, P., Niewiara, Ł., Kawulak, M., Szkodoń, K., Ostrowska-Kaim, E., Nosal, M., Krzanowski, M., Zmudka, K. F., Legutko, J., & Guzik, B. (2020) · Wiadomości Lekarskie · doi:10.36740/wlek202012108 · Cited by 10
Dong, X., Xie, Y., Xu, J., Qin, Y., Zheng, Q., Hu, R., Zhang, X., Wang, W., Tian, J., & Yi, K. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13509 · Cited by 10
Doku, A., Tuglo, L. S., Chilunga, F. P., Edzeame, J., Peters, R. J. G., & Agyemang, C. O. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03430-5 · Cited by 10
Liao, J., & Zhou, Z. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1142417 · Cited by 10
Ali, M., Lam, C. S. P., Strömberg, A., Hand, S., Booth, S., Zaccardi, F., Squire, I. B., McCann, G. P., Khunti, K., & Lawson, C. A. (2023) · Heart · doi:10.1136/heartjnl-2023-323295 · Cited by 10
Association between periodontal disease and coronary heart disease: A bibliometric analysis
Song, W., Bo, X.-W., Dou, H.-X., Fan, Q., & Wang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28325 · Cited by 10
Li, G.-X., Zhou, B., Qi, G., Zhang, B., Jiang, D., Wu, G.-M., Ma, B., Zhang, P., Zhao, Q., Li, J., et al. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.202742 · Cited by 10
Epidemiology of End-Stage Renal Failure
Trillini, M., Perico, N., & Remuzzi, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801734-0.00001-1 · Cited by 10
Kuzawa, C. W., Barrett, T. M., Borja, J. B., Lee, N. R., Aquino, C. T., Adair, L. S., & McDade, T. W. (2019) · American Journal of Human Biology · doi:10.1002/ajhb.23237 · Cited by 10
Jarauta, E., Laclaustra, M., Villa-Pobo, R., Langarita, R., Marco-Benedí, V., Bea, A. M., León-Latre, M., Casasnovas, J. A., & Civeira, F. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.07.039 · Cited by 10
Hypothyroidism and Heart Failure: Epidemiology, Pathogenetic Mechanisms & Therapeutic Rationale
Francois, J. C., Al‐Sadawi, M., Casillas, J. A., Botti, E., Soni, L., Ponse, D., Decamps, S., & McFarlane, S. I. (2020) · International Journal of Clinical Research & Trials · doi:10.15344/2456-8007/2020/146 · Cited by 10
A long noncoding RNACHAIRprotects the heart from pathological stress
Qian, Y., Zhang, M., Zhou, N., Xu, X., Zhang, J., Ding, Q., & Wang, J. (2020) · Clinical Science · doi:10.1042/cs20200149 · Cited by 10
Improvement of long-term clinical outcomes by successful PCI in the very elderly women with ACS
Wang, J., Guo, C., Chen, H., Li, H., Zhao, X.-Q., & Zhao, S.-M. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01933-7 · Cited by 10
Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis
Tsilimigras, D. I., Bibli, S., Siasos, G., Oikonomou, E. K., Perrea, D. N., Filis, K., Tousoulis, D. M., & Sigala, F. (2021) · Biomolecules · doi:10.3390/biom11050623 · Cited by 10
Orgil, B., Xu, F., Munkhsaikhan, U., Alberson, N. R., Bajpai, A. K., Johnson, J. N., Sun, Y., Towbin, J. A., Lu, L., & Purevjav, E. (2022) · Physiological Genomics · doi:10.1152/physiolgenomics.00120.2022 · Cited by 10
Are smokers less likely to seek preventive healthcare measures in Italy?
Carreras, G., Iannucci, L., Costa, G., Chellini, E., & Gorini, G. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000357 · Cited by 10
Cardiovascular magnetic resonance imaging in heart failure
Yoneyama, K., Kitanaka, Y., Tanaka, O., & Akashi, Y. J. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1445525 · Cited by 10
Why is ethnicity important in cardiovascular care?
Ski, C. F., Thompson, D. R., Fitzsimons, D., & King‐Shier, K. M. (2018) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515117741892 · Cited by 10
Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis
Ilić, M., & Ilić, I. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1935_15 · Cited by 10
Tanna, G. L. D., Chen, S., Bychenkova, A., Wirtz, H. S., Burrows, K. L., & Globe, G. A. (2019) · PharmacoEconomics - Open · doi:10.1007/s41669-019-00173-y · Cited by 10
Metadata
- Authors
- Roth, G. A., Forouzanfar, M. H., Moran, A. E., Barber, R., Nguyen, G., Feigin, V. L., Naghavi, M., Mensah, G. A., & Murray, C. J. L.
- Affiliations
- National Institutes of Health (US)
- University of Washington (US)
- Columbia University (US)
- Auckland University of Technology (NZ)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-02
- Volume
- 372
- Issue
- 14
- Pages
- 1333-1341
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4482354
- OpenAlex
- W1986019364
- Semantic Scholar
- 27a6b9a739f391969318dbfd3ffe6b84aa566d21
- Cited by
- 1,188
- References
- 14
- Citations by year
- 2026: 30 · 2025: 87 · 2024: 115 · 2023: 110 · 2022: 117 · 2021: 123 · 2020: 141 · 2019: 118 · 2018: 105 · 2017: 110 · 2016: 98 · 2015: 31
- FWCI
- 89.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K08HL089675)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Keywords
- cardiovascular mortality, population aging, population growth, age-specific mortality, counterfactual scenarios, GDP per capita, global health trends, regional variation in mortality
- MeSH terms
- Age Factors, Cardiovascular Diseases, Demography, Humans, Income, Mortality, Sex Factors, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
